Pre-made Ranevetmab benchmark antibody ( Canine Whole mAb, anti-NGFB/NGF therapeutic antibody, Anti-HSAN5 Antibody) for drug discovery and mechanism of action (MOA) research

Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Ranevetmab is a caninized monoclonal antibody that can be potentially used in the treatment of Osteoarthritis (OA). Specific Inquiry.

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No.	Package	Price(In USD)	Qty (Quantity)	Sum(In USD)
GMP-Bios-ab-469-1mg	1mg	3090
GMP-Bios-ab-469-10mg	10mg	Inquiry
GMP-Bios-ab-469-100mg	100mg	Inquiry
GMP-Bios-ab-469-xmg	＞100mg	Inquiry
			Shipping Cost:	760.00
			Total:

Description

Products Name (INN Index)	Pre-Made Ranevetmab biosimilar, Canine Whole mAb, Anti-NGFB/NGF Antibody: Anti-HSAN5 therapeutic antibody
INN Name	Ranevetmab
Target	NGF
Format	Canine Whole mAb
Derivation	Caninized
Species Reactivity	Canine
CH1 Isotype	IgG1
VD LC	Kappa
Highest_Clin_Trial (Jan '20)	Unknown
Est. Status	Active
100% SI Structure	None
99% SI Structure	None
95-98% SI Structure	None
Year Proposed	2016
Year Recommended	2017
Companies	Nexvet
Conditions Approved	na
Conditions Active	Osterarthritis
Conditions Discontinued	na
Development Tech	PETization Technology